IDH1 and glioma: The enzyme produced by IDH1 is pivotal in a key stage of the citric acid cycle; its mutation can trigger the abnormal accumulation of 2-hydroxyglutarate, resulting in the CpG island methylation phenotype and heightened histone methylation in glioma, which are deemed as critical early events in LGG (57).